4//SEC Filing
Canarick Robert 4
Accession 0001382218-23-000001
CIK 0001016504other
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 3:06 PM ET
Size
5.7 KB
Accession
0001382218-23-000001
Insider Transaction Report
Form 4
Canarick Robert
Director
Transactions
- Award
Stock Option (right to buy)
2023-07-18+50,000→ 50,000 totalExp: 2033-07-18→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The exercise price of each stock option will be the closing price of the Issuer's Common Stock on July 25, 2023, which represents the fifth trading day after the grant date.
- [F2]The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024.
Documents
Issuer
INTEGRATED BIOPHARMA INC
CIK 0001016504
Entity typeother
Related Parties
1- filerCIK 0001382218
Filing Metadata
- Form type
- 4
- Filed
- Jul 18, 8:00 PM ET
- Accepted
- Jul 19, 3:06 PM ET
- Size
- 5.7 KB